Drug data last refreshed 43m ago · AI intelligence enriched 1mo ago
Gallium Citrate GA 67 is a radioactive diagnostic imaging agent administered by injection used to detect certain infections, inflammations, and malignancies through nuclear medicine imaging. It functions as a tracer that localizes to areas of increased metabolic activity and bacterial/inflammatory burden. This legacy diagnostic radiopharmaceutical has been a cornerstone of nuclear medicine practice for over 45 years.
As a legacy diagnostic with approaching loss of exclusivity and minimal linked job activity, this product likely operates with a small, specialized team focused on maintaining existing market share in nuclear medicine departments.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Gallium Citrate GA 67 offers limited career advancement opportunities given the zero linked job postings and approaching loss of exclusivity. This role is best suited for professionals seeking niche expertise in legacy diagnostic radiopharmaceuticals or stable product maintenance rather than growth-oriented careers.
Worked on GALLIUM CITRATE GA 67 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.